Skip to content

Dexamethasone Versus Nalbuphine as Adjuvants in Brachial Plexus Block

Nalbuphine Versus Dexamethasone as an Adjuvant to Lidocaine / Bupivacaine Mixture in Ultrasound-guided Supraclavicular Brachial Plexus Block for Upper Limb Surgeries

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04194320
Enrollment
45
Registered
2019-12-11
Start date
2019-12-01
Completion date
2020-06-15
Last updated
2024-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia

Brief summary

Brachial plexus block is a very reliable method of regional anesthesia for the upper limb. It achieves ideal operating conditions by producing complete muscular relaxation and stable intraoperative hemodynamics.However,Local anesthetics alone have a shorter duration of postoperative analgesia. Hence,various adjuvants have been added to local anesthetics to achieve quick, dense, and prolonged block. This study assess and compare the efficacy of dexamethasone or nalbuphine as adjuvants to local anesthetics in supraclavicular brachial plexus block for upper limb surgeries.

Detailed description

Upper-limb surgeries can be performed under either general or regional anesthesia.However, regional anesthesia has the advantages of long-lasting pain relief & avoidance of airway instrumentation.Brachial plexus block is a very reliable method of regional anesthesia for the upper limb. It achieves ideal operating conditions by producing complete muscular relaxation and stable intraoperative hemodynamics.However,Local anesthetics alone have a shorter duration of postoperative analgesia. Hence,various adjuvants have been added to local anesthetics to achieve quick, dense, and prolonged block. This study assess and compare the efficacy of using 8 mg dexamethasone or 10 mg nalbuphine as adjuvants to local anesthetics mixture (Lidocaine 2% + bupivacaine 0.5% 1:1 mixture) in Ultrasound-guided supraclavicular brachial plexus block for upper limb surgeries below the level of the shoulder.

Interventions

PROCEDUREUltrasound (US) guided supraclavicular brachial plexus block

Using 8 mg dexamethasone or 10 mg nalbuphine as adjuvants to (Lidocaine 2% + bupivacaine 0.5% 1:1 mixture) in ultrasound (US) guided supraclavicular brachial plexus block

Sponsors

Zagazig University
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Patient acceptance. * American Society of Anesthesiologists (ASA) I and (ASA) II. * Age 21-60 years old. * Both gender. * BMI \< 30. * Accepted mental state of the patient. * Unilateral upper limb surgeries below the level of the shoulder.

Exclusion criteria

* Patient refusal. * Peripheral neuropathy. * Pathological coagulopathy. * Infection at the injection site. * History of active substance abuse. * Untreated pneumothorax. * Disturbed conscious level. * An allergy to local anesthetics or nalbuphine or dexamethasone. * Planned for receiving general anesthesia during the same operation for any cause.

Design outcomes

Primary

MeasureTime frameDescription
Duration of postoperative analgesiaFirst 24 hours after surgeryTime between onset of sensory block to the first report of postoperative pain at the surgical site that has a VAS visual analogue score ≥ 4.

Secondary

MeasureTime frameDescription
post operative pain score Visual Analogue ScoreFirst 24 hours after surgeryOn a scale of 0-10, the patient will be asked to quantify postoperative pain as the following: 0: No pain 10: Maximum/worst imaginable pain. Visual Analog Scale assessment will be done every 5 minutes for first 30 minutes, then hourly for first 8 hours then every 4 hourly till patient complained of pain equivalent to a VAS score of 4. Rescue analgesia (injection of fentanyl 25 mcg intravenous increments) up to 200 μg/hour is administered when VAS score reached 4.
The total opioid consumptionFirst 24 hours after surgeryTotal dose of fentanyl as a rescue analgesic in the first 24 hours

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026